These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11844674)

  • 21. Idarubicin DNA intercalation is reduced by MRP1 and not Pgp.
    Smeets ME; Raymakers RA; Vierwinden G; Pennings AH; Boezeman J; Minderman H; de Witte TM
    Leukemia; 1999 Sep; 13(9):1390-8. PubMed ID: 10482990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives.
    Yan F; Jiang Y; Li YM; Zhen X; Cen J; Fang WR
    Biol Pharm Bull; 2008 Jun; 31(6):1258-64. PubMed ID: 18520065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor agents. Part 204: synthesis and biological evaluation of substituted 2-aryl quinazolinones.
    Xia Y; Yang ZY; Hour MJ; Kuo SC; Xia P; Bastow KF; Nakanishi Y; Namrpoothiri P; Hackl T; Hamel E; Lee HK
    Bioorg Med Chem Lett; 2001 May; 11(9):1193-6. PubMed ID: 11354375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells.
    Tkaczyk-Gobis K; Tarasiuk J; Seksek O; Stefanska B; Borowski E; Garnier-Suillerot A
    Eur J Pharmacol; 2001 Feb; 413(2-3):131-41. PubMed ID: 11226386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
    Broxterman HJ; Feller N; Kuiper CM; Boven E; Versantvoort CH; Teerlink T; Pinedo HM; Lankelma J
    Int J Cancer; 1995 Jun; 61(6):880-6. PubMed ID: 7790125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
    Nagasawa K; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Biol Pharm Bull; 1996 Jul; 19(7):971-6. PubMed ID: 8839972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis, and Pharmacological Characterization of N-(4-(2 (6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)yl)ethyl)phenyl)quinazolin-4-amine Derivatives: Novel Inhibitors Reversing P-Glycoprotein-Mediated Multidrug Resistance.
    Qiu Q; Liu B; Cui J; Li Z; Deng X; Qiang H; Li J; Liao C; Zhang B; Shi W; Pan M; Huang W; Qian H
    J Med Chem; 2017 Apr; 60(8):3289-3302. PubMed ID: 28355069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter.
    Tiberghien F; Kurome T; Takesako K; Didier A; Wenandy T; Loor F
    J Med Chem; 2000 Jun; 43(13):2547-56. PubMed ID: 10891114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
    Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
    Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1).
    Schmitt SM; Stefan K; Wiese M
    J Med Chem; 2016 Apr; 59(7):3018-33. PubMed ID: 26943020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity studies of substituted quinoxalinones as multiple-drug-resistance antagonists.
    Lawrence DS; Copper JE; Smith CD
    J Med Chem; 2001 Feb; 44(4):594-601. PubMed ID: 11170649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
    Rhodes T; Barrand MA; Twentyman PR
    Br J Cancer; 1994 Jul; 70(1):60-6. PubMed ID: 7912544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and pharmacological activity of the stereoisomers of GP-88, a propafenone-type modulator of multidrug resistance.
    Chiba P; Rebitzer S; Richter E; Hitzler M; Ecker G
    Bioorg Med Chem Lett; 1998 Apr; 8(7):829-32. PubMed ID: 9871549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein.
    Starling JJ; Shepard RL; Cao J; Law KL; Norman BH; Kroin JS; Ehlhardt WJ; Baughman TM; Winter MA; Bell MG; Shih C; Gruber J; Elmquist WF; Dantzig AH
    Adv Enzyme Regul; 1997; 37():335-47. PubMed ID: 9381979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
    Fong WF; Shen XL; Globisch C; Wiese M; Chen GY; Zhu GY; Yu ZL; Tse AK; Hu YJ
    Bioorg Med Chem; 2008 Apr; 16(7):3694-703. PubMed ID: 18313307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport.
    Evers R; Kool M; Smith AJ; van Deemter L; de Haas M; Borst P
    Br J Cancer; 2000 Aug; 83(3):366-74. PubMed ID: 10917553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function.
    Chen ZS; Aoki S; Komatsu M; Ueda K; Sumizawa T; Furukawa T; Okumura H; Ren XQ; Belinsky MG; Lee K; Kruh GD; Kobayashi M; Akiyama S
    Int J Cancer; 2001 Jul; 93(1):107-13. PubMed ID: 11391629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers.
    Boer R; Gekeler V; Ulrich WR; Zimmermann P; Ise W; Schödl A; Haas S
    Eur J Cancer; 1996 May; 32A(5):857-61. PubMed ID: 9081366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.